Inhibition of rat hepatic glutathione S-transferase placental form positive foci development by concomitant administration of antioxidants to carcinogen-treated rats

Cancer Lett. 1990 Nov 19;55(1):25-9. doi: 10.1016/0304-3835(90)90061-2.

Abstract

Inhibition potential of concomitant butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), catechol or sodium ascorbate (Na-AsA) administration on development of diethylnitrosamine (DEN) initiated glutathione S-transferase placental form (GST-P) positive foci in rat liver under the influence of 2-acetylaminofluorene (2-AAF) or 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB) plus partial hepatectomy (PH) was investigated. Whereas BHA, BHT and catechol exerted marked inhibitory effects, Na-AsA lacked any modifying potential. The compounds that demonstrated inhibition also induced GST-P in the hepatic periportal areas, suggesting that development of GST-P positive foci is negatively influenced by extra-focal increase in this enzyme form observed with BHA, BHT or catechol.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Acetylaminofluorene
  • Animals
  • Ascorbic Acid / pharmacology*
  • Butylated Hydroxyanisole / pharmacology*
  • Catechols / pharmacology*
  • Diethylnitrosamine
  • Enzyme Induction / drug effects
  • Glutathione Transferase / biosynthesis*
  • Liver / enzymology*
  • Male
  • Methyldimethylaminoazobenzene
  • Rats
  • Rats, Inbred F344

Substances

  • Catechols
  • Butylated Hydroxyanisole
  • Diethylnitrosamine
  • Methyldimethylaminoazobenzene
  • 2-Acetylaminofluorene
  • Glutathione Transferase
  • catechol
  • Ascorbic Acid